Lilly’s Mounjaro leads to more and faster weight loss than Novo obesity drug, data analysis finds
By Nancy Lapid (Reuters) – Overweight or obese adults lost
lilly’s
Eli Lilly’s growth tied to nascent diabetes drug sales
(Reuters) – Wall Street analysts will be focusing on sales
U.S. FDA authorizes Eli Lilly’s COVID-19 antibody drug
-The U.S. Food and Drug Administration on Friday authorized Eli